Mark Hair's most recent trade in Treace Medical Concepts Inc was a trade of 11,547 Common Stock done . Disclosure was reported to the exchange on April 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Apr 2026 | 11,547 | 952,002 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 100,000 | 963,549 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2026 | 3,695 | 863,549 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2026 | 964 | 867,244 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 375,000 | 868,208 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 22 Jan 2026 | 17,037 | 493,208 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Jan 2026 | 8,719 | 510,245 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Aug 2025 | 22,212 | 518,964 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2025 | 3,684 | 541,176 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2025 | 961 | 544,860 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 187,500 | 546,821 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Jan 2025 | 8,594 | 359,321 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 207,260 | 367,915 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2024 | 4,088 | 160,655 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2024 | 1,067 | 164,743 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | L. Hair Mark | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 104,600 | 104,600 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 92,875 | 165,810 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 103,850 | 103,850 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 45,825 | 72,935 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.41 per share. | 09 Mar 2023 | 1,040 | 27,110 | - | 24.4 | 25,386 | Common Stock |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 92,100 | 92,100 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Mark L. Hair | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 11,950 | 21,950 | - | 0 | Common Stock |